Telemedicine Rash Evaluation and Assessment of Toxicity in Skin in Acute Oncology and Haematology Care: A Pilot Study
NCT07476807 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2026-04-28
Summary
This study is being done to find out if video consultations (telemedicine) can be used to safely and effectively assess and manage skin problems caused by cancer treatments. Instead of always coming to the hospital for a face-to-face appointment, the patient may be able to use thier smartphone or computer to show your skin to a nurse or doctor over a secure video call. the researchers want to see if this is as good as a regular clinic visit, and whether patients and staff are happy with this new way of working.
Conditions
- Rash
- Systemic Treatments
- Tele-assessment
Interventions
- OTHER
-
telem healthassessment
SOC is face to face assessment-this study aims to use telemedecine toassess Treatment related skin disorders
Sponsors & Collaborators
-
Sligo General Hospital
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-04-01
- Primary Completion
- 2026-04-01
- Completion
- 2026-09-12
Countries
- Ireland
Study Locations
More Related Trials
-
Safety and Efficacy Study of Electrotransfer of Plasmid AMEP to Treat Advanced or Metastatic Melanoma
NCT01045915 ·Status: TERMINATED ·Phase: PHASE1
-
Selumetinib in Treating Patients With Locally Advanced or Metastatic Liver Cancer
NCT00604721 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment With Nab-paclitaxel in Cutaneous SCC
NCT02076243 ·Status: TERMINATED ·Phase: PHASE2
-
Selumetinib and Akt Inhibitor MK2206 in Treating Patients With Stage III or Stage IV Melanoma Who Failed Prior Therapy With Vemurafenib or Dabrafenib
NCT01519427 ·Status: TERMINATED ·Phase: PHASE2
-
Effects of Epidermal Growth Factor Receptor Inhibitor Therapy in the Skin of Cancer Patients
NCT00483457 ·Status: COMPLETED
-
A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
NCT06066138 ·Status: RECRUITING ·Phase: PHASE1
-
Tanespimycin in Treating Patients With Stage III-IV Melanoma
NCT00087386 ·Status: TERMINATED ·Phase: PHASE2
-
Neoadjuvant Use of Talimogene Laherparepvec and BRAF/MEK Inhibitor for Advanced Nodal BRAF Mutant Melanoma
NCT03972046 ·Status: WITHDRAWN ·Phase: PHASE2
-
Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors
NCT03176485 ·Status: COMPLETED ·Phase: NA
-
Selinexor in Patients With Advanced Thymoma and Thymic Carcinoma
NCT03466827 ·Status: UNKNOWN ·Phase: PHASE2
-
Phase 2 Study of the Poly(ADP-Ribose) Polymerase Inhibitor E7016 in Combination With Temozolomide in Subjects With Wild Type BRAF Stage IV or Unresectable Stage III Melanoma
NCT01605162 ·Status: TERMINATED ·Phase: PHASE2
-
Selumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By Surgery
NCT01859182 ·Status: WITHDRAWN ·Phase: PHASE2
-
Combining Talimogene Laherparepvec With BRAF and MEK Inhibitors in BRAF Mutated Advanced Melanoma
NCT03088176 ·Status: UNKNOWN ·Phase: PHASE1
-
Hydroxychloroquine and Temozolomide in Treating Patients With Metastatic or Unresectable Solid Tumors
NCT00714181 ·Status: COMPLETED ·Phase: PHASE1
-
Topical Myristyl Nicotinate Cream on the Skin of Healthy Volunteers
NCT00619060 ·Status: COMPLETED ·Phase: PHASE1
-
MEDI4736 Combinations in Metastatic Renal Cell Carcinoma
NCT02819596 ·Status: COMPLETED ·Phase: PHASE2
-
Vemurafenib, Cobimetinib, Atezolizumab, and Tiragolumab in Treating Patients With High-Risk Stage III Melanoma
NCT03554083 ·Status: COMPLETED ·Phase: PHASE2
-
Study of TVEC in Patients With Cutaneous Squamous Cell Cancer
NCT03714828 ·Status: COMPLETED ·Phase: PHASE2
-
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Malignant Melanoma
NCT00104897 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Metronidazole Cream in the Prevention and Treatment of Tarceva (Erlotinib)-Associated Rash
NCT00642473 ·Status: COMPLETED ·Phase: PHASE2
-
Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye Melanoma
NCT00003802 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer
NCT02797964 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
T-VEC in Non-melanoma Skin Cancer
NCT03458117 ·Status: COMPLETED ·Phase: PHASE1
-
Phase II Trial of Neoadjuvant Temozolomide in Melanoma Patients With Palpable Stage III or IV Disease Undergoing Complete Surgical Resection
NCT00588341 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Trial of Extended-Dosing Temozolomide in Patients With Melanoma
NCT00591370 ·Status: COMPLETED ·Phase: PHASE2